TearLab (TearLab) Total Inventories : $1.95 Mil (As of Mar. 2020)

View and export this data going back to 2004. Start your Free Trial

What is TearLab Total Inventories?

TearLab's total inventories for the quarter that ended in Mar. 2020 was $1.95 Mil. TearLab's average total inventories from the quarter that ended in Dec. 2019 to the quarter that ended in Mar. 2020 was $2.11 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. TearLab's Net-Net Working Capital per share for the quarter that ended in Mar. 2020 was $-2.60.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. TearLab's Days Inventory for the three months ended in Mar. 2020 was 103.39.

Inventory Turnover measures how fast the company turns over its inventory within a year. TearLab's Inventory Turnover for the quarter that ended in Mar. 2020 was 0.88.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. TearLab's Inventory-to-Revenue for the quarter that ended in Mar. 2020 was 0.41.

TearLab Total Inventories Historical Data

The historical data trend for TearLab's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TearLab Total Inventories Chart

TearLab Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Total Inventories

Get a 7-Day Free Trial

3.97

3.19

2.00

1.99

2.27

TearLab Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20
Total Inventories	Get a 7-Day Free Trial															2.21	2.83	2.90	2.27	1.95

TearLab Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

TearLab (OTCPK:TEAR) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

TearLab's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2020 is

	Net-Net Working Capital Per Share (Q: Mar. 2020 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(7.335	+	0.75 * 0.936	+	0.5 * 1.948	-	41.648
-	0	-	0)	/	12.5606
=	-2.60

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

TearLab's Days Inventory for the three months ended in Mar. 2020 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2020 )	/	Cost of Goods Sold (Q: Mar. 2020 )	*	Days in Period
	=	2.1085	/	1.861	*	365 / 4
	=	103.39

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

TearLab's Inventory Turnover for the quarter that ended in Mar. 2020 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Mar. 2020 )	/	Average Total Inventories (Q: Mar. 2020 )
	=	1.861	/	2.1085
	=	0.88

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

TearLab's Inventory to Revenue for the quarter that ended in Mar. 2020 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Mar. 2020 )	/	Revenue (Q: Mar. 2020 )
	=	2.1085	/	5.091
	=	0.41

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

TearLab Total Inventories Related Terms

Thank you for viewing the detailed overview of TearLab's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

TearLab (TearLab) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » TearLab Corp (OTCPK:TEAR) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

N/A

Address

150 LaTerraza Boulevard, SuiteÂ 101, Escondido, CA, USA, 92025

Website

http://www.tearlab.com

TearLab Corp is a part of the diagnostic industry. It is an in-vitro diagnostic company based in the United States. TearLab has commercialized a proprietary tear testing platform, the TearLab Osmolarity System that enables eye care practitioners to test for highly sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The company operates through its wholly-owned subsidiary, TearLab Research Inc. Most of the company's revenue is derived from the United States region.

Executives

Anthony E Altig	director	C/O OPTIMER PHARMACEUTICALS, INC, 101 HUDSON STREET, JERSEY CITY NJ 07302
Cr Group L.p.	10 percent owner	1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Lindstrom Richard L Md	director	2811 WESTWOOD PL, WAYZATA MN 55391
Awm Investment Company, Inc.	10 percent owner	527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022
Adrienne L Graves	director	125 STONE MOUNTAIN CIRCLE, NAPA CA 94558
Gilbert S Omenn	director	AMGEN INC., ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320-1799
John Y Caloz	officer: Chief Financial Officer	ETON AVE, C/O INTERNATIONAL REMOTE IMAGING SYS, CHATSWORTH CA 91311